Saturday, May 9, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle

"vaccine"

  • Tipping point

    Developments on vaccine front offer a tentative timeline on when it could be available on a mass scale
  • Sensex, Nifty scale record high levels supported by positive vaccine news

    Tata Steel was the top gainer in the Sensex pack, rising over 4 per cent, followed by Bharti Airtel, SBI, HDFC Bank, M&M, Asian Paints and Reliance Industries.
  • New vaccine breakthrough lifts global hope against pandemic

    Moderna, whose results stem from a clinical trial of more than 30,000 participants, expects to have approximately 20 million doses ready to ship in the United States by year-end.
  • Biological E starts phase I/II trial of Covid-19 vaccine

    The vaccine candidate includes an antigen in-licensed from BCM Ventures, Baylor College of Medicine’s integrated commercialisation team, along with Dynavax’s advanced adjuvant CpG 1018.
  • UK to run final stage trials of Janssen Covid vaccine

    Dr. Saul Faust, who is helping lead the study, said the research will start first in Britain but aims to recruit a total of 30,000 people in six countries around the world.
  • Russian vaccine arrives in India for human clinical trial

    The vaccine supplies for the global market will be produced by RDIF's international partners in India, Brazil, China, South Korea and other countries.
  • Australian Covid-19 vaccine ready for later-stage clinical trials

    Regulatory approval was being sought for the vaccine to progress to Phase 3 clinical trials before the end of the year.
  • Serum Institute, ICMR complete enrolment in phase-III trials for COVID-19 vaccine

    SII and ICMR are conducting phase II/III clinical trial of the vaccine at 15 different centres across the country.
  • ‘Covid-19 vaccine being developed in record time’

    Hyderabad: The Covid-19 vaccine development is happening at a much faster pace when compared to other vaccines and it is pushing the innovation and manufacturing capabilities of developed and developing countries. Speaking at the 28th Annual Hysea Innovation Summit, Bharat Biotech MD Dr Krishna Ella said that the pandemic vaccine coming out in 12 months […]
  • Dr Reddy’s partners with BIRAC for Sputnik V vaccine trials in India

    Collaboration will allow Dr Reddy’s to identify and use some of the Biotechnology Industry Research Assistance Council’s clinical trial centres
  • Drugs Controller General of India nod for Covaxin phase 3 trials

    The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3)
  • COVID-19 vaccine coming in weeks: Trump; Biden says US about to go into dark winter

    The coronavirus dominated the opening minutes of the Trump-Biden face-off with President Trump terming the contagion a “worldwide problem”.
  • Vaccine trials ‘can’t detect’ virus risk reduction: Expert

    The World Health Organisation (WHO) has identified 42 candidate vaccines in clinical trials, ten of which are in the most advanced "phase 3" stage.
  • Indonesia to provide COVID-19 vaccine to 9.1 million people at 1st phase

    The first phase of vaccination will be carried out on the groups of people with highest risk of COVID-19 infections.
  • Dr Reddy’s, RDIF receive approval to conduct clinical trial for Sputnik V vaccine

    This will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study, Dr Reddy’s said in a statement.
  • Apollo Hospitals prepared to administer 10 lakh vaccine doses per day

    Whenever the Union government makes a vaccine available, the Apollo Hospitals will leverage its robust pan-India web of 19 medicine supply hubs with cold chain facilities.
  • Paris goes under curfew as Europe ramps up virus restrictions

    With over one million coronavirus deaths and nearly 40 million cases worldwide, regions like Europe that suppressed the first outbreak are again facing tough choices on how to control a new wave.
  • Covid-19 reinfection casts doubt on virus immunity: Study

    "The possibility of reinfections could have significant implications for our understanding of Covid-19 immunity, especially in the absence of an effective vaccine."
  • Indian-origin researchers use bovine adenovirus to develop Covid vax

    Bovine Adenovirus, also known as BAdV, is a member of the Adenoviridae family that causes disease in cattle.
  • Australia plans big spending pandemic measures, record debt

    The annual budget is expected to contain a wage subsidy to get unemployed young Australians back to work.
« 1 … 12 13 14 15 »

Latest News

  • Jagan accuses Naidu government of misusing police machinery in Andhra Pradesh

    1 min ago
  • Andhra Pradesh Chief Justice inaugurates new court complex in East Godavari

    3 mins ago
  • Modi and Shah pay tribute to BJP workers at Bengal oath ceremony

    11 mins ago
  • Kalyani Priyadarshan set for Cannes debut on May 14 amid ‘Lokah’ success

    3 mins ago
  • Anish wins gold at KSSMSC

    14 mins ago
  • Chidvilas Sai leads Brilliant Trophy Rapid Chess Tournament

    16 mins ago
  • No cracks in INDIA alliance, says Sanjay Raut amid DMK-Congress row

    18 mins ago
  • Approach road of second bridge across river Godavari sinks in Kothagudem

    18 mins ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam